Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wiese

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
The American Journal of Medicine|October 24, 2000
Are physicians aware of which of their patients have indwelling urinary catheters?S Saint, J Wiese, J K Amory, et al.
Obesity (Silver Spring, Md.)|January 29, 2008
Insurance coverage and incentives for weight loss among adults with metabolic syndromeDavid Arterburn, Emily O Westbrook, Cheryl J Wiese, et al.
International Journal of Molecular Sciences|January 12, 2021
<i>Arabidopsis</i> bZIP18 and bZIP52 Accumulate in Nuclei Following Heat Stress where They Regulate the Expression of a Similar Set of GenesAnna J Wiese, Lenka Steinbachová, Ljudmilla Timofejeva, et al.
The Lancet. Diabetes & Endocrinology|September 24, 2022
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trialHiddo J L Heerspink, Naveed Sattar, Imre Pavo, et al.
The Journal of Biological Chemistry|September 1, 1995
Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulinD F Lazar, R J Wiese, M J Brady, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 22, 2009
The HSG procedure for modelling integrated urban wastewater systemsD Muschalla, M Schütze, K Schroeder, et al.
Critical Care Medicine|November 21, 1997
Effects of crystalloid solutions on circulating lactate concentrations: Part 1. Implications for the proper handling of blood specimens obtained from critically ill patientsE V Jackson, J Wiese, B Sigal, et al.
Diabetes Care|January 2, 2025
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical TrialsEllen M Apperloo, Katherine R Tuttle, Imre Pavo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2023
Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial ProgrammeKristina S Boye, Vivian Thuyanh Thieu, Hélène Sapin, et al.
Cardiovascular Diabetology|February 10, 2024
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial ProgramStephen J Nicholls, Santiago Tofé, Carel W le Roux, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
The American Journal of Medicine|October 24, 2000
Are physicians aware of which of their patients have indwelling urinary catheters?S Saint, J Wiese, J K Amory, et al.
Obesity (Silver Spring, Md.)|January 29, 2008
Insurance coverage and incentives for weight loss among adults with metabolic syndromeDavid Arterburn, Emily O Westbrook, Cheryl J Wiese, et al.
International Journal of Molecular Sciences|January 12, 2021
<i>Arabidopsis</i> bZIP18 and bZIP52 Accumulate in Nuclei Following Heat Stress where They Regulate the Expression of a Similar Set of GenesAnna J Wiese, Lenka Steinbachová, Ljudmilla Timofejeva, et al.
The Lancet. Diabetes & Endocrinology|September 24, 2022
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trialHiddo J L Heerspink, Naveed Sattar, Imre Pavo, et al.
The Journal of Biological Chemistry|September 1, 1995
Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulinD F Lazar, R J Wiese, M J Brady, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 22, 2009
The HSG procedure for modelling integrated urban wastewater systemsD Muschalla, M Schütze, K Schroeder, et al.
Critical Care Medicine|November 21, 1997
Effects of crystalloid solutions on circulating lactate concentrations: Part 1. Implications for the proper handling of blood specimens obtained from critically ill patientsE V Jackson, J Wiese, B Sigal, et al.
Diabetes Care|January 2, 2025
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical TrialsEllen M Apperloo, Katherine R Tuttle, Imre Pavo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2023
Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial ProgrammeKristina S Boye, Vivian Thuyanh Thieu, Hélène Sapin, et al.
Cardiovascular Diabetology|February 10, 2024
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial ProgramStephen J Nicholls, Santiago Tofé, Carel W le Roux, et al.
Pageof 16